Stock Events

Stock Events

Virax Biolabs Group (VRAX) Q4 2025 Earnings

2DecConfirmed

Q3 2024

Q4 2024

Q3 2025

Q4 2025

-12.25

-11.92

-11.58

-11.25

Details

Expected EPS

N/A

Actual EPS

-12.25

Surprise EPS

-12.25

Surprise Percent

+∞%

Description

Virax Biolabs Group (VRAX) has reported earnings of -12.25 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.